Iovance Biotherapeutics Inc (IOVA) Ownership

11.71 ↓0.15 (-1.26%)
As of April 24, 2024, 4:00pm EST.

Institutional Ownership

Vanguard Group Inc is the biggest individual institutional holder of Iovance Biotherapeutics Inc (IOVA), owning a total of 22.8 million shares. Combined, the top 36 institutional holders of IOVA own 77.29% of the company with a total of 205.9 million shares.

In the latest ownership report on December 31st 2023, the top 36 institutional holders increased their combined ownership of IOVA by 3.3 million shares. 9 institutions bought 6,786,825 total additional shares and increased their ownership by an average of 19.03%. However 8 institutions sold 3,535,639 total shares and decreased their ownership by an average of 7.99%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Iovance Biotherapeutics increased by a net total of 3,251,186 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Vanguard Group Inc8.168%3.023%22,812,820669,3502023-12-31
Mhr Fund Management Llc7.160%0.000%19,997,10302023-12-31
BlackRock Inc6.828%3.784%19,071,756695,3272023-12-31
State Street Corporation5.880%-1.840%16,424,388-307,8812023-12-31
Perceptive Advisors LLC4.289%0.138%11,979,41516,4772023-12-31
Goldman Sachs Group Inc2.636%95.638%7,363,1203,599,4822023-12-31
venBio Select Advisor LLC2.399%0.000%6,700,00002023-12-31
Pictet Asset Manangement SA1.884%-23.871%5,263,309-1,650,3752023-12-31
Geode Capital Management, LLC1.803%6.057%5,037,098287,6872023-12-31
Artisan Partners Limited Partnership1.728%-4.146%4,827,670-208,8092023-12-31
Orbimed Advisors, LLC1.685%0.000%4,707,45802023-12-31
Balyasny Asset Management LLC1.406%-12.301%3,926,159-550,6772023-12-31
Morgan Stanley - Brokerage Accounts1.330%49.692%3,715,5451,233,4202023-12-31
Dimensional Fund Advisors, Inc.1.259%-11.598%3,516,987-461,3982023-12-31
MPM Oncology Impact Management LP1.178%0.063%3,289,4702,0732023-12-31
T. Rowe Price Associates, Inc.1.173%-8.910%3,276,602-320,5182023-12-31
JPMorgan Chase & Co1.017%3.398%2,839,66793,3112023-12-31
Credit Suisse First Boston (CSFB)1.008%-1.025%2,814,316-29,1532023-12-31
Principal Financial Group Inc0.944%-0.258%2,636,327-6,8282023-12-31
Northern Trust Corp0.782%9.517%2,182,877189,6982023-12-31

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Vanguard Group Inc8.168%3.023%22,812,820669,3502023-12-31
Mhr Fund Management Llc7.160%0.000%19,997,10302023-12-31
BlackRock Inc6.828%3.784%19,071,756695,3272023-12-31
State Street Corporation5.880%-1.840%16,424,388-307,8812023-12-31
Perceptive Advisors LLC4.289%0.138%11,979,41516,4772023-12-31
Millennium Management LLC2.804%118.397%7,820,0744,239,4062023-09-30
Point72 Asset Management, L.P.3.043%-11.512%7,786,985-1,013,0742023-06-30
Goldman Sachs Group Inc2.636%95.638%7,363,1203,599,4822023-12-31
venBio Select Advisor LLC2.399%0.000%6,700,00002023-12-31
Pictet Asset Manangement SA1.884%-23.871%5,263,309-1,650,3752023-12-31
Geode Capital Management, LLC1.803%6.057%5,037,098287,6872023-12-31
Artisan Partners Limited Partnership1.728%-4.146%4,827,670-208,8092023-12-31
Orbimed Advisors, LLC1.685%0.000%4,707,45802023-12-31
Balyasny Asset Management LLC1.406%-12.301%3,926,159-550,6772023-12-31
Morgan Stanley - Brokerage Accounts1.330%49.692%3,715,5451,233,4202023-12-31
Boxer Capital LLC1.328%0.000%3,705,13302023-09-30
Dimensional Fund Advisors, Inc.1.259%-11.598%3,516,987-461,3982023-12-31
Citadel Advisors Llc1.403%51.350%3,472,0311,177,9892023-03-31
Deutsche Bank AG1.294%258.187%3,311,9802,387,3302023-06-30
MPM Oncology Impact Management LP1.178%0.063%3,289,4702,0732023-12-31
T. Rowe Price Associates, Inc.1.173%-8.910%3,276,602-320,5182023-12-31
Renaissance Technologies Corp1.427%295.857%3,200,9002,392,3002022-12-31
NORGES BANK1.325%128.580%2,974,8571,673,4072022-12-31
JPMorgan Chase & Co1.017%3.398%2,839,66793,3112023-12-31
Credit Suisse First Boston (CSFB)1.008%-1.025%2,814,316-29,1532023-12-31
Candriam Luxembourg S.C.A.1.074%59.036%2,747,8531,020,0372023-09-30
Franklin Resources Inc1.091%-18.163%2,699,983-599,2392023-03-31
Principal Financial Group Inc0.944%-0.258%2,636,327-6,8282023-12-31
Sumitomo Mitsui Trust Holdings Inc1.039%-0.561%2,573,091-14,5272023-03-31
Ameriprise Financial Inc1.120%-16.540%2,512,167-497,8472022-09-30
Nikko Asset Management Americas Inc1.005%-2.291%2,490,600-58,3912023-06-30
D. E. Shaw & Co LP1.052%-44.100%2,359,951-1,861,8092023-03-31
ARK Investment Management LLC1.468%-21.067%2,317,217-618,4622022-09-30
Northern Trust Corp0.782%9.517%2,182,877189,6982023-12-31
Rice Hall James & Associates, LLC1.154%27.058%1,822,080388,0242022-12-31
Nuveen Asset Management, LLC1.101%-3.345%1,738,385-60,1642022-09-30

Mutual Fund Ownership

Vanguard Total Stock Mkt Idx Inv is the biggest individual fund holder of Iovance Biotherapeutics Inc (IOVA), owning a total of 7.9 million shares. Combined, the top 34 mutual fund holders of IOVA own 32.51% of the company with a total of 85.4 million shares.

In the latest ownership report on March 31st 2024, the top 34 fund holders increased their combined ownership of IOVA by 63 thousand shares. 2 funds bought 87,795 total additional shares and increased their ownership by an average of 2.50%. However 1 funds sold 25,087 total shares and decreased their ownership by an average of 1.64%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding Iovance Biotherapeutics increased by a net total of 62,708 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
SPDR® S&P Biotech ETF1.752%0.536%4,892,52426,0952024-03-31
JPM Thematics Genetic Thrps C2 Acc USD0.540%-1.635%1,509,269-25,0872024-03-31
State St Russell Sm/Mid Cp® Indx NL Cl C0.517%4.461%1,444,85661,7002024-03-31

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Vanguard Total Stock Mkt Idx Inv2.819%9.654%7,873,458693,1972024-02-29
Vanguard Small Cap Index2.317%10.019%6,470,878589,2682024-02-29
iShares Russell 2000 ETF2.081%0.048%5,812,0342,8022024-03-28
SPDR® S&P Biotech ETF1.752%0.536%4,892,52426,0952024-03-31
Vanguard Small Cap Value Index Inv1.581%9.858%4,416,734396,3352024-02-29
Vanguard Instl Ttl Stck Mkt Idx Tr1.648%-7.978%4,216,673-365,5462023-03-31
Vanguard Institutional Extnd Mkt Idx Tr1.284%11.000%3,585,795355,3372024-02-29
Vanguard Extended Market Index Investor1.200%-0.018%2,973,790-5272023-08-31
Worldwide Healthcare Ord1.024%0.000%2,858,87802023-12-31
Artisan Small Cap Investor0.911%-5.439%2,545,427-146,4082023-12-31
Artisan U.S. Small-Cap Growth0.911%-5.439%2,545,427-146,4082023-12-31
Fidelity Small Cap Index0.831%1.639%2,321,84137,4472024-01-31
ARK Genomic Revolution1.026%-19.526%2,299,675-557,9912022-09-30
iShares Russell 2000 Value ETF0.799%-0.063%2,230,498-1,4142024-03-28
Fidelity® Small Cap Index0.864%2.806%2,211,94260,3782023-10-31
Nikko AM ARK Pstv Chg Innovt P JPY Acc0.804%0.000%1,989,88202023-06-30
Pictet-Biotech P USD0.685%-34.805%1,912,552-1,021,0402023-12-31
CS (Lux) Digital Health Equity SB USD0.645%-21.739%1,800,000-500,0002024-02-29
ARK Genomic Revolution ETF1.106%-2.389%1,745,642-42,7162022-11-30
Candriam Global Equities Oncology0.677%83.917%1,731,403790,0002023-09-30
iShares Biotechnology ETF0.577%-0.394%1,611,418-6,3702024-03-28
Franklin Biotechnology Discv A(acc)USD0.707%0.000%1,586,82302023-04-30
JPM Thematics Genetic Thrps C2 Acc USD0.540%-1.635%1,509,269-25,0872024-03-31
T. Rowe Price Health Sciences0.533%-13.698%1,489,682-236,4372023-12-31
State St Russell Sm/Mid Cp® Indx NL Cl C0.517%4.461%1,444,85661,7002024-03-31
Franklin Biotechnology Discovery A0.884%0.000%1,395,90102022-10-31
Fidelity Extended Market Index0.490%11.612%1,368,746142,4012024-02-29
C WorldWide Healthcare Select 1A0.488%0.000%1,360,00002024-01-31
Direxion Daily S&P Biotech Bull 3X ETF0.519%3.801%1,327,73148,6202023-12-28
Pictet-Global Megatrend Sel I USD0.471%-27.889%1,315,838-508,8912023-12-31
Belfius Equities Cure C Cap0.466%-31.189%1,191,403-540,0002023-11-30
Schwab US Small-Cap ETF™0.407%0.000%1,137,21102024-03-29
T. Rowe Price New Horizons0.498%-1.142%1,117,328-12,9022023-03-31
Fidelity® Extended Market Index0.446%0.000%1,105,41702023-08-31

Discussions

Please log in or register to share your thoughts.